A detailed history of Consolidated Capital Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Consolidated Capital Management, LLC holds 2,735 shares of BSX stock, worth $236,358. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,735
Previous 2,735 -0.0%
Holding current value
$236,358
Previous $210,000 9.05%
% of portfolio
0.1%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$67.33 - $77.71 $184,147 - $212,536
2,735 New
2,735 $210,000
Q2 2021

Jul 22, 2021

SELL
$38.58 - $44.24 $249,651 - $286,277
-6,471 Closed
0 $0
Q1 2021

Apr 19, 2021

BUY
$35.27 - $39.67 $228,232 - $256,704
6,471 New
6,471 $250,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $124B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Consolidated Capital Management, LLC Portfolio

Follow Consolidated Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Capital Management, LLC with notifications on news.